FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2037267867> ?p ?o ?g. }

• W2037267867 endingPage "68" @default.
• W2037267867 startingPage "68" @default.
• W2037267867 abstract "The differential diagnosis of biliary stenosis is a critical problem for gastroenterologists. An early identification of malignant lesions would enable the rapid resort to surgical resection which currently represents the only potentially curative option. Unfortunately, the diagnostic value of all available methods (e.g. imaging technics, standard serum biomarkers) is limited by relatively poor accuracy and negative predictive value. Recently, our group and others highlighted new potential cancer biomarkers in bile by using comparative proteomic analysis. Nevertheless, to date, only a few candidates have been verified for their diagnostic performances in discriminating between malignant and non-malignant stenoses. In addition, no data have yet been collected on the simultaneous measurement of these proteins with the intent of evaluating the diagnostic interest of a panel of biomarkers. To overcome the limitation of classical verification tools and give a new impetus to the translation of bile biomarkers into clinical diagnostics, mass spectrometry-based quantification could represent a rapid and cost-effective opportunity thanks to its capacity for multiplexed, high-throughput analysis, combined with its analytical specificity and reliable quantification. Here we developed the first Selected Reaction Monitoring (SRM) assay for the multiplexed measurement of cancer biomarkers in human bile. For this purpose, 8 potential biomarker candidates previously highlighted by proteomic analysis were selected. Equal volumes of bile collected from patients presenting with malignant and non-malignant biliary stenosis were stacked on the top of a SDS-PAGE gel. Proteins were then digested in-gel with trypsin and proteotypic peptides of each candidate biomarker were quantified by nanoLC-SRM on a 5500-QTrap mass spectrometer (ABSciex) using heavy synthetic peptides as standards (PEPotecTM, Thermofisher). SRM data were finally analysed using Skyline software and manual validation. The developed assay proved to be valuable and reliable to quantify all the selected candidates. Moreover, the results confirmed the simultaneous overexpression of some of the proteins in bile samples from malignant stenoses. Overall, our data demonstrate the ability of SRM to quantify cancer biomarkers in human bile and emphasize the interest of using multiplexed SRM assays to assess the diagnostic potential of a panel of bile biomarkers in differentiating biliary stenoses. Work supported by the PRIME-XS consortium." @default.
• W2037267867 created "2016-06-24" @default.
• W2037267867 creator A5022343141 @default.
• W2037267867 creator A5025367066 @default.
• W2037267867 creator A5027595144 @default.
• W2037267867 creator A5042172053 @default.
• W2037267867 creator A5071424520 @default.
• W2037267867 creator A5085304931 @default.
• W2037267867 date "2015-02-07" @default.
• W2037267867 modified "2023-09-26" @default.
• W2037267867 title "SRM-Based quantification of malignant biliary stenosis biomarkers in human bile" @default.
• W2037267867 doi "https://doi.org/10.1016/j.nhtm.2014.11.046" @default.
• W2037267867 hasPublicationYear "2015" @default.
• W2037267867 type Work @default.
• W2037267867 sameAs 2037267867 @default.
• W2037267867 citedByCount "0" @default.
• W2037267867 crossrefType "journal-article" @default.
• W2037267867 hasAuthorship W2037267867A5022343141 @default.
• W2037267867 hasAuthorship W2037267867A5025367066 @default.
• W2037267867 hasAuthorship W2037267867A5027595144 @default.
• W2037267867 hasAuthorship W2037267867A5042172053 @default.
• W2037267867 hasAuthorship W2037267867A5071424520 @default.
• W2037267867 hasAuthorship W2037267867A5085304931 @default.
• W2037267867 hasBestOaLocation W20372678671 @default.
• W2037267867 hasConcept C126322002 @default.
• W2037267867 hasConcept C126838900 @default.
• W2037267867 hasConcept C2780007028 @default.
• W2037267867 hasConcept C71924100 @default.
• W2037267867 hasConcept C90924648 @default.
• W2037267867 hasConceptScore W2037267867C126322002 @default.
• W2037267867 hasConceptScore W2037267867C126838900 @default.
• W2037267867 hasConceptScore W2037267867C2780007028 @default.
• W2037267867 hasConceptScore W2037267867C71924100 @default.
• W2037267867 hasConceptScore W2037267867C90924648 @default.
• W2037267867 hasIssue "2" @default.
• W2037267867 hasLocation W20372678671 @default.
• W2037267867 hasOpenAccess W2037267867 @default.
• W2037267867 hasPrimaryLocation W20372678671 @default.
• W2037267867 hasRelatedWork W2028807226 @default.
• W2037267867 hasRelatedWork W2299824099 @default.
• W2037267867 hasRelatedWork W2374372804 @default.
• W2037267867 hasRelatedWork W2407894235 @default.
• W2037267867 hasRelatedWork W2414762393 @default.
• W2037267867 hasRelatedWork W2415036099 @default.
• W2037267867 hasRelatedWork W2438645318 @default.
• W2037267867 hasRelatedWork W4247326819 @default.
• W2037267867 hasRelatedWork W4253797189 @default.
• W2037267867 hasRelatedWork W4297264101 @default.
• W2037267867 hasVolume "2" @default.
• W2037267867 isParatext "false" @default.
• W2037267867 isRetracted "false" @default.
• W2037267867 magId "2037267867" @default.
• W2037267867 workType "article" @default.